Exosomes are small vesicles that are found in nearly all eukaryotic fluids and facilitate a range of important cellular functions. It has been long known that stem cells have the potential to exert therapeutic effects, but it only now being recognized that exosomes play an important role how these effects occur.
Over the past few years, this recognition has fueled a market for products and technologies leveraging stem cell exosomes. Key events in the formation of this market are highlighted in the timeline below.
Timeline of Exosome Industry Events
For those that want a text-based guide to exosome industry events:
May 6, 2014 – Capricor Therapeutics enters exclusive worldwide license with Cedars-Sinai Medical Center for IP relating to exosomes from cardiosphere-derived cells (CDCs)
November 17, 2015 – Codiak Biosciences launches with $80M in investor funding (largest venture-backed exosome company ever)
December 1, 2016 – Kimera Labs announces 6,000 sq ft, ISO:9001 certified exosome production facility in Florida
December 8, 2016 – Exosome Diagnostics launches first instrument for exosomal protein (exoProtein) capture and analysis directly from any biofluid
December 13, 2016, – Creative Medical Technology Holdings files U.S. patent for use of AmnioStem as a production method for exosomes to regenerate damaged brain tissue
January 26, 2016 – Codiak Biosciences secures $61 million Series B round
May, 2, 2017– ExoCoBio Inc. raises $11 million in Series A funding round
May 5, 2017 – Altnia spins out Exopharm Pty Ltd, a specialist company with a patented purification technology called LEAP to make exomeres in large scale and at low cost
Are there any events missing from this list? Comment below and we will add them.